Delivery Order SPE2DB20D3303-SPE2DB24FZ0S1
- Not listed
- The U.S. government's Defense Logistics Agency (DLA) awarded a $13,787.74 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a pharmaceutical product used for the treatment of diabetes. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up to $999,999,999.00, which provides a comprehensive range of pharmaceutical...
- This federal contract award, valued at $8,829.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a pharmaceutical product used for diabetes management. This is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, worth up to $999,999,999.00 and running through November 2026. The contract does not have a set-aside...
- This federal contract award, valued at $6,224.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a diabetes medication, with a performance period ending on May 10, 2024. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December...
- This federal contract award, valued at $10,449.36, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a specialty medication used for diabetes management. This award is part of a larger Indefinite Delivery Contract (IDC) between the DLA and Cencora, Inc., valued at up to $999,999,999.00, that serves as the primary vehicle for the company to...
- This federal contract award, valued at $10,449.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 7, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA...
- This federal contract award, valued at $5,224.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a pharmaceutical product, with a completion date of November 8, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a specialty medication used for diabetes management. The contract has a ceiling value of $11,627.83 and a completion date of January 24, 2024. This appears to be a delivery order against a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,967.89 firm fixed-price delivery order is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used for diabetes management. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for...
- This federal contract award, valued at $1,741.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a pharmaceutical product, to support federal healthcare programs. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025....
- This federal contract award, valued at $8,356.05, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml medication. This is a firm fixed-price delivery order contract with a completion date of March 7, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB24FZ0S1Delivery Order
This federal contract award, valued at $10,654.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used to treat diabetes. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs. The contract has a firm fixed price pricing type and a period of performance through March 2024. There is no set-aside designation indicated for this specific award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.7k | 2/29/24 |